Joyce S, Mathew J M, Flye M W, Mohanakumar T
Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110.
Transplantation. 1992 May;53(5):1119-27. doi: 10.1097/00007890-199205000-00027.
Tissue specific non-MHC alloantigens play a crucial role in allograft immunity. However, their structural properties have remained elusive, largely due to their inability to induce a strong antibody response. We report the characterization of a monkey heteroantiserum, MHK-I, raised against human kidney cells, that serologically reacts specifically with kidney cells after extensive absorptions of anti-HLA class I and II reactivities. The non-MHC MHK-I-binding molecule(s) is expressed only in the renal cortex on the glomerulus, peritubular capillaries, venous endothelium, and tubular epithelium. Immunochemically, MHK-I recognizes a kidney-specific non-MHC alloantigen of Mr 90,000 to 100,000 (90 kD). These properties of MHK-I are similar to those of the previously characterized alloantibodies eluted from rejected kidneys. These alloantibodies bind to the kidney from which the antibody was eluted and to a few others but are unlike MHK-I, which binds to extracts prepared from all human kidneys. Biochemical analysis by two-dimensional electrophoresis (pI ranging between 4.5 and 5.5) and peptide fingerprinting provide further evidence that the alloantigen is polymorphic. These findings imply that the non-MHC kidney-specific molecule(s) may function as target(s) for immune destruction of renal allografts.
组织特异性非主要组织相容性复合体(MHC)同种异体抗原在同种异体移植免疫中起关键作用。然而,它们的结构特性一直难以捉摸,这主要是因为它们无法诱导强烈的抗体反应。我们报告了一种针对人肾细胞产生的猴异种抗血清MHK-I的特性,在大量吸收抗HLA I类和II类反应性后,该抗血清与肾细胞发生特异性血清学反应。非MHC的MHK-I结合分子仅在肾皮质的肾小球、肾小管周围毛细血管、静脉内皮和肾小管上皮中表达。免疫化学分析表明,MHK-I识别一种分子量为90,000至100,000(90 kD)的肾特异性非MHC同种异体抗原。MHK-I的这些特性与先前从排斥肾中洗脱的同种异体抗体的特性相似。这些同种异体抗体与洗脱抗体的肾脏以及其他一些肾脏结合,但与MHK-I不同,MHK-I与所有人类肾脏制备的提取物结合。二维电泳(等电点范围在4.5至5.5之间)和肽指纹图谱的生化分析进一步证明该同种异体抗原具有多态性。这些发现表明,非MHC肾特异性分子可能作为肾同种异体移植免疫破坏的靶点。